Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1969 Feb 15;1(5641):404–406. doi: 10.1136/bmj.1.5641.404

Cough and Cold Remedies: a Potential Danger to Patients on Monoamine Oxidase Inhibitors

M F Cuthbert, M P Greenberg, S W Morley
PMCID: PMC1981898  PMID: 5763957

Abstract

Experiments have been carried out in healthy volunteers to study the effects of phenylpropanolamine on the blood pressure and possible interactions with monamine oxidase inhibitors.

In three subjects 50 mg. of phenylpropanolamine taken orally produced a modest rise of systolic pressure. Two proprietary preparations containing this dose in a slow-release form had no significant effect on the blood pressure. In all three subjects 100 mg. of phenylpropanolamine taken orally caused a more pronounced rise of systolic pressure and a rise of diastolic pressure.

In contrast, 50 mg. of phenylpropanolamine orally caused a rapid and potentially dangerous rise of blood pressure in a subject taking the monamine oxidase inhibitor tranylcypromine, and a similar acute rise of blood pressure occurred in this subject when given a proprietary cough linctus containing the same dose of phenylpropanolamine. These and other results suggest that severe hypertensive episodes are more likely to occur when preparations containing phenylpropanolamine in a free form, rather than in slow-release form, are taken by patients being treated with monoamine oxidase inhibitors.

The acute rise of blood pressure due to the interaction of phenylpropanolamine and monoamine oxidase inhibitors was reversed by intramuscular injection of phentolamine.

Full text

PDF
404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLACKWELL B. HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORS. Lancet. 1963 Oct 26;2(7313):849–850. doi: 10.1016/s0140-6736(63)92743-0. [DOI] [PubMed] [Google Scholar]
  2. BLACKWELL B., MARLEY E. INTERACTION BETWEEN CHEESE AND MONOAMINE-OXIDASE INHIBITORS IN RATS AND CATS. Lancet. 1964 Mar 7;1(7332):530–531. doi: 10.1016/s0140-6736(64)92914-9. [DOI] [PubMed] [Google Scholar]
  3. Elis J., Laurence D. R., Mattie H., Prichard B. N. Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure. Br Med J. 1967 Apr 8;2(5544):75–78. doi: 10.1136/bmj.2.5544.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GARROW J. S. ZERO-MUDDLER FOR UNPREJUDICED SPHYGMOMANOMETRY. Lancet. 1963 Dec 7;2(7319):1205–1205. doi: 10.1016/s0140-6736(63)92929-5. [DOI] [PubMed] [Google Scholar]
  5. Rand M. J., Trinker F. R. The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors. Br J Pharmacol Chemother. 1968 Jun;33(2):287–303. doi: 10.1111/j.1476-5381.1968.tb00990.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. TONKS C. M., LLOYD A. T. HAZARDS WITH MOMOAMINE-OXIDASE INHIBITORS. Br Med J. 1965 Feb 27;1(5434):589–589. doi: 10.1136/bmj.1.5434.589-b. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES